Advertisement.

ACRV Projected Dividend Yield

Acrivon Therapeutics Inc ( NASDAQ : ACRV )

Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines by utilizing its proprietary proteomics-based patient responder identification platform. Co.'s Clinical Candidate ACR-368 is a selective small molecule inhibitor targeting CHK1 and CHK2. Using its Acrivon Predictive Precision Proteomics (AP3) platform, Co. has developed a predictive OncoSignature test for ACR-368, called ACR-368 OncoSignature that can predict patient response to ACR-368 monotherapy. Co. also has two preclinical drug programs designed to take advantage of its AP3 platform and the ability to predict tumor sensitivity based on custom OncoSignature tests.

20 YEAR PERFORMANCE RESULTS

ACRV Dividend History Detail
ACRV Dividend News
ACRV Competitors News

# of Shares: 0

Closing Price: 7.06

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000